scholarly journals A retrospective study of tuberculosis prevalence amongst patients attending a tertiary hospital in Riyadh, Saudi Arabia

Author(s):  
Souad M. Alateah ◽  
Maha W. Othman ◽  
Medina Ahmed ◽  
Mohammed S. Al Amro ◽  
Nisreen Al Sherbini ◽  
...  
BMJ Open ◽  
2018 ◽  
Vol 8 (5) ◽  
pp. e020852 ◽  
Author(s):  
Monira Alwhaibi ◽  
Bander Balkhi ◽  
Tariq M Alhawassi ◽  
Hadeel Alkofide ◽  
Nouf Alduhaim ◽  
...  

2019 ◽  
pp. 001857871988231
Author(s):  
Oluwaseun Egunsola ◽  
Sheraz Ali ◽  
Dalal S. Al-Dossari ◽  
Rahsid Hamoud Alnajrani

Background: The peculiarities of medication errors (MEs) among the pediatric population in the Middle East have not been adequately explored. In this study, we describe the MEs reported at the largest tertiary hospital in Saudi Arabia. Methods: This study is a retrospective analysis of MEs reported by health care professionals at a large tertiary hospital in Saudi Arabia between 2015 and 2016. Results: There were a total of 9123 MEs involving 84 different medications. In total, 109 382 drugs were ordered. Thus, 8.3 MEs per 100 prescriptions were reported during the study period. Thirty-nine errors (0.4%) reached the patient, but did not cause any harm. Transcribing errors accounted for more than half of the MEs (n = 4856, 53.2%). Physicians were the least likely to report an ME (n = 159, 1.7%), whereas pharmacists reported more MEs than any other health care professional (n = 4924, 54%). The most common drug causes of MEs were paracetamol, salbutamol, and amoxicillin, which accounted for 21.0%, 16.6%, and 12.4% of MEs, respectively, over the study period. Conclusions: Medication errors are common in pediatric care, especially for drugs such as paracetamol and amoxicillin that are frequently prescribed. Transcription error was common in this study and is more likely to be reported by pharmacists.


Author(s):  
Mariam Al-Garni ◽  
Roaa Alqabbaa ◽  
Noha Qummosani ◽  
Dhuha Khesfaty ◽  
Abaad Almutairi ◽  
...  

2020 ◽  
Vol 21 (3) ◽  
pp. 159-164
Author(s):  
Turki Aldrees ◽  
Mohammed Alqabasani ◽  
Riyadh Alhedaithy ◽  
Saleh Alqaryan ◽  
Abdullah Alshalan ◽  
...  

2020 ◽  
Vol 16 (4) ◽  
pp. 327-333
Author(s):  
Shannon Armstrong-Kempter ◽  
Lucinda Beech ◽  
Sarah J. Melov ◽  
Adrienne Kirby ◽  
Roshini Nayyar

Background: The discovery of the benefits of antenatal corticosteroids (ACS) for preterm infants was one of the most significant developments in obstetric care. However, due to the difficulty in predicting preterm delivery, optimal use of ACS, is challenging. Objective: To describe prescribing practices for antenatal corticosteroids (ACS) at a tertiary hospital over five years to determine whether ACS were received at optimal timing; to determine patient characteristics of women receiving ACS at optimal timing; to determine patient characteristics of those who did not receive ACS as indicated and to examine the trend in ACS prescribing over the study period. Methods: We performed a retrospective study of all deliveries from January 2011 to December 2015. The rates of ACS prescription for each group of women (preterm, late preterm, and term) were recorded and analysed. Results: A total of 65% of women who delivered before 34 weeks’ gestation received ACS. Of these women, 63% delivered within 7 days of receiving ACS. Women most likely to receive ACS with optimal timing were primiparous (relative risk [RR], 1.25 [CI, 1.08-1.45]), or women diagnosed with pre-eclampsia (RR, 1.34 [CI 1.10-1.63]), preterm premature rupture of membranes (RR, 1.33 [CI, 1.15-1.54]) or threatened preterm labour (RR, 1.42 [CI, 1.22-1.65]). Conclusion: A significant number of women and babies are exposed to ACS without commensurate benefit, and a significant number who deliver preterm do not receive ACS. The percentage of preterm and term infants receiving ACS should be determined to optimise service delivery.


Sign in / Sign up

Export Citation Format

Share Document